Law360, New York (November 18, 2009, 4:23 PM ET) -- Leading Democrats in the House of Representatives have asked the U.S. Government Accountability Office to study trends in prescription drug prices, saying drug companies may be inflating prices in anticipation of health care reforms intended to drive prices down.
The letter, dated Tuesday, was signed by Rep. Charles B. Rangel, D-N.Y., chair of the House Ways and Means Committee; Rep. Henry A. Waxman, D-Calif., chair of the Energy and Commerce Committee; Rep. Pete Stark, D-Calif., chair of the Ways and Means health subcommittee; and Rep. John...
House Dems Ask GAO To Look At Drug Prices
To view the full article, take a free trial now.
